Neuland Laboratories Stock Price Analysis and Quick Research Report. Is Neuland Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Neuland Laboratories. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Neuland Laboratories has a PE ratio of 114.165758346454 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Neuland Laboratories has ROA of 12.9418% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Neuland Laboratories has a Current ratio of 2.4064.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Neuland Laboratories has a ROE of 18.5801%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Neuland Laboratories has a Debt to Equity ratio of 0.0897 which means that the company has low proportion of debt in its capital.

• Sales growth: Neuland Laboratories has reported revenue growth of -5.2447% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Neuland Laboratories for the current financial year is 21.8235888272865%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Neuland Laboratories is Rs 12 and the yield is 0.0772%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Neuland Laboratories is Rs 136.2405. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Neuland Laboratories in Ticker for free. Also, one can get the intrinsic value of Neuland Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Neuland Laboratories FAQs

Q1. What is Neuland Laboratories share price today?
Ans: The current share price of Neuland Laboratories is Rs 15554.

Q2. What is the market capitalisation of Neuland Laboratories?
Ans: Neuland Laboratories has a market capitalisation of Rs 19955.6093506 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Neuland Laboratories?
Ans: The PE ratio of Neuland Laboratories is 114.165758346454 and the P/B ratio of Neuland Laboratories is 13.0378621057899, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Neuland Laboratories share?
Ans: The 52-week high share price of Neuland Laboratories is Rs 18100, and the 52-week low share price of Neuland Laboratories is Rs 10190.7.

Q5. Does Neuland Laboratories pay dividends?
Ans: Currently, Neuland Laboratories pays dividends. Dividend yield of Neuland Laboratories is around 0.0772%.

Q6. What are the face value and book value of Neuland Laboratories shares?
Ans: The face value of Neuland Laboratories shares is Rs 10, while the book value per share of Neuland Laboratories is around Rs 1192.987. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Neuland Laboratories?
Ans: Neuland Laboratories has a total debt of Rs 136.0101 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Neuland Laboratories?
Ans: The ROE of Neuland Laboratories is 18.5801% and ROCE of Neuland Laboratories is 23.4905%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Neuland Laboratories a good buy for the long term?
Ans: The Neuland Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Neuland Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Neuland Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Neuland Laboratories’s financials?
Ans: You can review Neuland Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.